Adult T cell leukemia (ATLL) develops in 3 ± 5% of HTLV-1 carriers after a long period of latency during which a persistent polyclonal expansion of HTLV-1 infected lymphocytes is observed in all individuals. This incubation period is signi®cantly shortened in HTLV-1 carrier with Strongyloides stercoralis (Ss) infection, suggesting that Ss could be a cofactor of ATLL. As an increased T cell proliferation at the asymptomatic stage of HTLV-1 infection could increase the risk of malignant transformation, the eect of Ss infection on infected T lymphocytes was assessed in vivo in HTLV-1 asymptomatic carriers. After real-time quantitative PCR, the mean circulating HTLV-1 proviral load was more than ®ve times higher in HTLV-1 carriers with stongyloidiasis than in HTLV-1+ individuals without Ss infection (P50.009). This increased proviral load was found to result from the extensive proliferation of a restricted number of infected clones, i.e. from oligoclonal expansion, as evidenced by the semiquantitative ampli®-cation of HTLV-1¯anking sequences. The positive eect of Ss on clonal expansion was reversible under eective treatment of strongyloidiasis in one patient with parasitological cure whereas no signi®cant modi®cation of the HTLV-1 replication pattern was observed in an additional case with strongyloidiasis treatment failure. Therefore, Ss stimulates the oligoclonal proliferation of HTLV-1 infected cells in HTLV-1 asymptomatic carriers in vivo. This is thought to account for the shortened period of latency observed in ATLL patients with strongyloidiasis. Oncogene (2000) 19, 4954 ± 4960.
Introduction
HTLV-1, the ®rst human pathogenic retrovirus isolated, is the etiologic agent of a malignant CD4 lymphoproliferation (adult T-cell leukemia/lymphoma [ATLL]) (Poiesz et al., 1980; Yoshida et al., 1982) and of a chronic progressive neuromyelopathy (tropical spastic paraparesis [TSP/HAM]) (Gessain et al., 1985; Osame et al., 1986) . Furthermore, this virus has been associated, though to a lesser extent, to the development of a variety of in¯ammatory diseases (Eguchi et al., 1992; LaGrenade et al., 1990; Mattos et al., 1993; Mochizuki et al., 1994; Sato et al., 1991; Sherman et al., 1995) . Among the 15 ± 25 million individuals infected worldwide, approximately 3 ± 5% will develop ATLL, depending on as yet unknown cofactors. Infection early in life is crucial in the development of ATLL. However, the average age of onset is 60 years in Japan but only 40 in Jamaica, Trinidad and Brazil (Cleghorn et al., 1995; Pombo de Oliveira et al., 1995) . In vivo, the HTLV-1 life cycle includes the proliferation of its host cell and persistent clonal expansion of circulating CD4 T-cells harboring the HTLV-1 provirus has been evidenced in all symptomatic and asymptomatic carriers (Cavrois et al., 1996a (Cavrois et al., ,b, 1998 Leclercq et al., 1998) .
Strongyloides stercoralis (Ss) causes strongyloidiasis, a chronic, usually asymptomatic, gastrointestinal infection (Goyal, 1998; Molbak et al., 1994) . It is found in the same endemic area as HTLV-1 (Gelber and Rodrig, 1996) . A signi®cant correlation between HTLV-1 and Ss infections has been evidenced in endemic regions (Hayashi et al., 1997) . The decreases in serum levels of IgE and IgE-binding factor in HTLV-1 infected individuals may help explain this association (Matsumoto et al., 1990; Newton et al., 1992) . However, other studies have reported that these two infections occur independently (Arakaki et al., 1992a,b) . In immunocompromized hosts or in patients receiving immunosuppressive therapy, an extreme multiplication of the parasite could occur, with the dissemination of larvae to most organs in the body (DeVault et al., 1990; Gordon et al., 1994) . Such opportunistic hyperinfection has been reported in HTLV-1 infected individuals, especially in patients with ATLL (Massey et al., 1990; Nonaka et al., 1998; Pagliuca, 1999; Pagliuca et al., 1988; Phelps et al., 1991) .
The ®nding that a persistent clonal expansion of HTLV-1 bearing cells precedes ATLL suggests that the tumor cells in ATLL may have arisen from a clonally expanding non-malignant cell, presumably by the acquisition of subsequent mutations in genes such as p53 or p16 (Cavrois et al., 1996b; Cesarman et al., 1992; Hatta et al., 1995) . Since a mutant T cell is formed only if it divides (Albertini et al., 1990) , any factor that triggers the clonal expansion of HTLV-1 bearing cells may increase the risk of critical mutations and shorten the latency phase preceding ATLL. Interestingly, a monoclonal integration of the HTLV provirus in peripheral blood mononuclear cells (PBMCs), as evidenced by Southern blotting, has been reported in about 40% of HTLV-1 carriers with strongyloidiasis . By contrast, Southern-blotting, which has a sensitivity of about 1/20, failed to detect any signal in HTLV-1 infected individuals without strongyloidiasis (Chen et al., 1995; Nakada et al., 1987; Yamaguchi et al., 1988) . In addition, Ss has been found to signi®cantly shorten the incubation period of ATLL, which occurs 30 years earlier in HTLV-1 individuals with strongyloidiasis than in other HTLV-1 asymptomatic carriers (Cleghorn et al., 1995; Plumelle et al., 1997; Pombo de Oliveira et al., 1995; Yamaguchi et al., 1987) . Indeed, a greater exposure to infectious agents including Ss has been proposed to explain the earlier onset of ATLL in Caribbean/African patients when compared to Japanese patients .
These data suggest that, through the stimulation of infected T cell proliferation, Ss could be a cofactor of ATLL. The low sensitivity of the Southern blotting precludes the detection of HTLV-1 integration in most carriers. Consequently, the eect of Ss on the clonality of HTLV-1 infected T-cell remains unknown in about 60% of individuals. In the present study, two sensitive PCR based protocols were used in order to assess the pattern of HTLV-1 replication in all HTLV-1 carriers with strongyloidiasis. First, real-time quantitative PCR analysis revealed that the HTLV-1 proviral load was signi®cantly increased during strongyloidiasis. Secondly, semiquantitative analysis of circulating HTLV-1 positive clones was performed by ligation mediated PCR (LMPCR) ampli®cation of HTLV-1 integration sites. The detection threshold of this method is about 1 HTLV-1 integration site per 3000 cells (Cavrois et al., 1995) . The results show that the extensive proliferation of a restricted number of HTLV-1 infected clones, rather than being an occasional phenomenon, was the norm for HTLV-1 carriers with strongyloidiasis.
Results

High proviral load in HTLV-1 carriers with strongyloidiasis
Deletions of the HTLV-1 proviral sequence are frequently observed in PBMC samples derived from asymptomatic or symptomatic carriers (Ohshima et al., 1991; Shimamoto et al., 1994; Tamiya et al., 1996; Tsukasaki et al., 1997) . However, all these defective proviruses retain the 3' Px region that encodes the regulatory viral proteins. To avoid underestimating the proviral load by quantitative PCR, we therefore used Px speci®c oligonucleotides. The lower limit of detection was 10 copies per 1.5610 5 PBMCs. As shown in Table 1 , we estimated the absolute copy number of HTLV-1 proviral DNA per 1.5610 5 PBMCs. Each sample was analysed in triplicate and . It was noteworthy that the copy number in Ss+/HTLV-1+ was signi®cantly higher than that of the 10 patients Figure 1 Quadruplicate LMPCR analysis of samples from HTLV-1 carriers with or without strongyloidiasis. For each sample, 2 mg of DNA were studied through four experiments. After digestion by NlaIII, linear and exponential ampli®cation, four cycles of linear PCR were performed with a 5'-32 P-radiolabeled HTLV-1 (+) strand speci®c primer. Each band on the gels corresponds to a cluster of identical HTLV-1¯anking sequence. Since HTLV-1 does not integrate in a speci®c region of the cellular genome, each signal corresponds to a cluster of proviruses sharing the same integration site and thus derived from a single HTLV-1 infected progenitor. The abundance of each clone is proportionate to its frequency of detection after quadruplicate experiment. Accordingly, clones detected once, two to three times, and four times correspond to 50 to 100, 100 to 500, and more than 500 copies in 1 mg of DNA, respectively (see text for details) Figure 2 Distribution of the circulating infected clones between HTLV-1 carriers with or without strongyloidiasis according to their clonal frequency. The clonal frequency was assessed by quadruplicate LMPCR (Figure 1 ). As detailed in the Materials and methods section, clones detected once, twice or three times, and four times had a clonal frequency of 51/3000 to 51/1500 PBMCs, 51/1500 to 51/300 PBMCs, and 51/300 PBMCs, respectively. The proportion of clones belonging to each of these three categories was compared between HTLV-1 carriers with or without strongyloidiasis using the Mann-Whitney test with TSP/HAM (mean 10240; P=0.014, MannWhitney test).
High level of infected T-cell oligoclonal proliferation in HTLV-1 carriers with strongyloidiasis
Having found an elevated proviral load in Ss+/HTLV-1+ individuals we subsequently investigated the clonal distribution of the integrated proviruses within circulating lymphocytes in HTLV-1 carriers with or without strongyloidiasis. Semiquantitative assessment of the clonality of HTLV-1 infected lymphocytes was assessed through quadruplicate LMPCR. The detection threshold of LMPCR is 50 copies in 150 000 PBMCs. Therefore, each signal observed after run-o analysis (Figure 1 ) corresponds to a cluster of at least 50 cells derived from a single HTLV-1 infected progenitor. Signals detected once, two or three times, and four times after four LMPCR experiments correspond to 50 ± 100, 100 ± 500, and more than 500 copies in 1 mg of DNA, respectively (Cavrois et al., 1995) . Infected clones detected once after quadruplicate analysis were de®ned as having a polyclonal pattern of replication, whereas those detected more frequently, i.e two to four times, were de®ned as having an oligoclonal distribution.
Typical data concerning HTLV-1 integration sites derived from three Ss+ and three Ss-individuals are presented in Figure 1 , while Figure 2 and Table 1 summarize the results obtained for the 33 HTLV-1 carriers studied. It is evident from Figure 1 that the frequency of abundant clones, i.e. those detected more than once after quadruplicate experiment, was higher in Ss+/HTLV-1+ patient than in HTLV-1 asymptomatic carrier without strongyloidiasis. For example, the number of clones detected four times and having a cloning frequency of 51/300 ranged from 0 ± 5 in the three Ss-/HTLV-1+ patients on Figure 1 versus ®ve to 12 in the remaining three cases with strongyloidiasis.
After quadruplicate LMPCR, the overall number of HTLV-1 positive clones was signi®cantly higher in Ss+/HTLV-1+ than in Ss-/HTLV-1+ individuals (Figure 2 , Table 1 ). It ranged from 20 ± 52 in Ss+/ HTLV-1+ (mean+s.e.m. 39+2; median 38), and from 23 ± 46 in Ss-/HTLV-1+ (mean+s.e.m. 32+2; median 31, P=0.024, Mann-Whitney test). Interestingly, this resulted from a strong dierence in the distribution of these clones among polyclonal and oligoclonal forms between HTLV-1 carriers with or without strongyloidiasis. Indeed, the proportion of clones having a clonal frequency that range from 1/3000 to 1/1500 was signi®cantly lower in the Ss+/HTLV-1+ group, when compared to the SS-/HTLV-1+ group (Table 1, Figure  2 ). It ranged from eight to 25 in Ss+/HTLV-1+ (mean+s.e.m. 17+1; median 18), and from 15 ± 33 in Ss-/HTLV-1+ (mean+s.e.m. 24+1; median 23). This dierence was statistically signi®cant (P=0.0003, Mann-Whitney test). By contrast, the proportion of clones of more than 1/1500 infected PBMCs, i.e. those detected at least two times after quadruplicate experiments, was signi®cantly higher in the Ss+/ HTLV-1+ group, when compared to the Ss-/HTLV-1+ group (Table 1, Figure 2 ). It ranged from 11 ± 33 in Ss+/HTLV-1+ (mean+s.e.m. 22+2; median 22.5), and from 0 ± 26 in Ss-/HTLV-1+ (mean+s.e.m. 7+2; median 2). This dierence was statistically signi®cant (P510 4 , Mann-Whitney test). It is of note that infected clones with a frequency of 51/300 PBMCs were present in the 18 patients with strongyloidiasis and in only ®ve of the 15 HTLV-1 carriers without Ss infection. As shown in Figure 2 , the proportion of these clones was signi®cantly higher in HTLV-1 carriers with strongyloidiasis (P=0.003).
Clonality pattern of HTLV-1 infected cells after treatment of strongyloidiasis
The proviral load and the clonality pattern of circulating HTLV-1 infected cells were analysed before and after treatment of strongyloidiasis with thiabendazol in patients PPI2462 and PPI2464 (Table 1) . Figure  3 summarizes the pattern of replication over time in both individuals. A second PBMC sample from patient PPI2462 was studied 12 months after the ®rst analysis. At that time, stools remained positive for Ss larvae. As shown in Figure 3 , the proviral load increased from 3250 ± 4694. Regarding the clonality pattern of circulating lymphocytes harboring an integrated HTLV-1 provirus, no signi®cant¯uctuation was noticed for both the overall number of clones and the proportion of clones at the frequency of 51/1500 infected PBMCs. A second PBMC sample from patient PPI2464 was studied 12 months after the ®rst analysis. At that time, stools were found repeatedly negative for Ss larvae. As shown in Figure 3 , the circulating proviral load decreased from 10281 to 2067. Regarding the clonality pattern of circulating lymphocytes harboring an integrated HTLV-1 provirus, the overall number of clones appeared to remain stable, whereas the number of clones of 51/1500 infected PBMC decreased from 11 to 3 (Figure 3 ).
Discussion
The data indicate that, in HTLV-1 carriers, strongyloidiasis is associated with high circulating proviral loads that result from the extensive proliferation of a restricted number of HTLV-1 infected clones on a background of polyclonally expanded HTLV-1 positive cells.
With the exception of carrier H1217026, who had one the highest proviral load described to date for an asymptomatic carrier, the viral copy number and the clonality pattern of HTLV-1 infected cells observed here for patients with TSP/HAM and carriers without strongyloidiasis correspond to those previously described (Gessain et al., 1990; Shinzato et al., 1991; Wattel et al., 1992) . By contrast, strongyloidiasis was found to be associated with extremely high proviral loads, with up to 1/2 PBMCs harboring HTLV-1. Quadruplicate LMPCR analysis revealed that, rather than resulting from a polyclonal expansion as in TSP/ HAM and carriers without strongyloidiasis, the high proviral load associated with Ss infection corresponds to a pattern of oligoclonal expansion. About 30% of HTLV-1 carriers without strongyloidiasis harbor circulating clones of more than 1/300 infected PBMCs. By contrast, 3 ± 12 clones with similar frequency are observed in 100% of HTLV-1 carriers with strongyloidiasis.
HTLV-1 mainly replicates through host cell immortalization. This is due to the eect of the viral Tax oncoprotein, which keeps the infected CD4 T lymphocyte cycling (Cross et al., 1987; Duyao et al., 1992; Fujii et al., 1991; Inoue et al., 1986; Suzuki et al., 1996) . In addition, through the inactivation of some DNA repair functions of the host cell (Jeang et al., 1990; Jin et al., 1998; Kao and Marriott, 1999; Philpott and Buehring, 1999 ; PiseMasison et al., 1998), Tax exerts a mutagenic eect in vitro (Miyake et al., 1999) . In such context, the increased infected T cell proliferation associated with Ss infection is thought to increase the frequency of acquired T cell somatic mutations leading to malignant transformation. Therefore, present results help explain why the latency period of ATLL is signi®cantly shortened in patients with strongyloidiasis (Cleghorn et al., 1995; Plumelle et al., 1997; Yamaguchi et al., 1987) .
The successful treatment of strongyloidiasis in patient PPI2464 was found to be associated with a decreased proviral load, together with a change in the clonality of HTLV-1 bearing cells towards a pattern identical to that observed in carriers without parasitic infection (Figure 3, patient PPI2464 ). By contrast, in patient PPI2462, the pattern of HTLV-1 replication remained stable under treatment in the absence of parasitological cure (Figure 3, patient PPI2462) . In both patients, DNA samples were analysed at 12 monthly intervals, meaning that the decrease in infected T-cell proliferation cannot be attributed to a thiabendazol-associated leukopenia, which is a rare adverse eect occuring only transiently after treatment. This suggests that the increased oligoclonal proliferation of HTLV-1 infected cells observed in patients with strongyloidiasis appears to be the consequence of Ss infection rather than a simple co-occurrence. However, a spontaneous¯uctuation of both the proviral load and the pattern of clonality could also explain the results observed in both patients, independently from the anti-helminthic treatment. Further studies are needed in order to analyse additional DNA samples before and after antihelminthic therapy. This work will help con®rm that the negative eects of such treatment on both HTLV-1 proviral load and infected T-cell proliferation result from the clearance of the parasite.
The positive eect of a parasitic infection on the development of a lymphotropic virus-associated lymphoma is reminiscent of the well-known synergic association between Epstein-Barr virus (EBV) infection and malaria in the genesis of Burkitt lymphoma (BL) (de The, 1997 The, , 1985 Facer and Playfair, 1989) . As ATLL with HTLV-1, BL has a complex, multistep pathogenesis, in which EBV is the best documented, but almost certainly not the only, contributing factor. Epidemiologically, hyperendemic malaria increases the incidence of BL by a factor of 20 in Africa (de The, 1997). For HTLV-1, the incidence of strongyloidiasis seems to be higher in ATLL patients than in asymptomatic HTLV-1 infected individuals. In Martinique, the French West Indies, the prevalence of Ss infection in the general population is about 2% whereas 20% of Ss-infected individuals are coinfected by HTLV-1 (Patey et al., 1992) . In the same area, the prevalence of Ss infection in ATLL is 42 versus 23% in other T-cell lymphomas (Agape et al., 1999) . Pathogenically, EBV-associated lymphomagenesis is assumed to result from the malaria-associated chronic stimulation of germinal center cell proliferation together with a possible acquired EBV-speci®c T-cell immune de®ciency. In the case of ATLL, present results show that Ss increases the proliferation of HTLV-1 infected T-cells by a mechanism which remains to be elucidated.
In conclusion, the increased oligoclonal proliferation of infected T cells observed in HTLV-1 carriers with Figure 3 HTLV-1 replication pattern over time in two HTLV-1 carriers treated for strongyloidiasis. DNA samples were analysed at 12 monthly intervals for both patients treated by thiabendazol in the 5 days following the ®rst analysis. The HTLV-1 proviral load was measured by real-time quantitative PCR. The number of circulating HTLV-1 positive clones was determined by quadruplicate LMPCR. The clinical history of the two HTLV-1 infected individuals is detailed in the results section strongyloidiasis is expected to help move the cellular clones towards a transformed phenotype, of which ATLL is the end point. This helps explain the shortened period of latency observed in ATLL patients with strongyloidiasis. Strongyloidiasis is asymptomatic in about 50% of the cases (Goyal, 1998; Molbak et al., 1994) . Future experiments are needed in order to con®rm that the positive eect of Ss on clonal expansion is reversible under eective treatment of Ss infection. Finally, present results emphasize the need to assess the eect of other endemic pathogens on the clonality pattern of HTLV-1 infected cells, especially in areas where ATLL develops after a short incubation period.
Materials and methods
Samples
PBMC DNA samples were obtained from 18 Ss+/HTLV-1+ patients and from 15 Ss-/HTLV-1+ asymptomatic individuals. Eight Ss+/HTLV-1+ patients and eight Ss-/HTLV-1+ carriers were from French Guyana and lived in the same area. Ten Ss+/HTLV-1+ patients and seven Ss-/HTLV-1+ carriers were from Martinique, the French West Indies. Sera were ®rst tested for antibodies to HTLV-1 associated antigen by ELISA. HTLV-1 seropositivity was then con®rmed by Western blot analysis.
Ss infection was detected by using a search of rhabditiform larvae on fresh stools by the Baerman method. Strongyloidiasis was asymptomatic in all the eight Ss+/HTLV-1+ patients.
Six uninfected DNA samples served as negative control. Positive controls corresponded to DNA samples extracted from PBMCs that derived from 10 patients with TSP/HAM and two HTLV-1 cell lines.
Quantification of the HTLV-1 proviral load in PBMCs from infected individuals HTLV-1 proviral load was assessed by an accurate and reproducible quantitative PCR method using a dual-labeled uorescent probe (ABI PRISM 7700 Sequence detection system). Standard curves for the albumin and HTLV-1 tax genes were generated using DNA extracted from HTLV-1 negative PBMCs for the former and an HTLV-1 plasmid for the latter. It was assumed that 10 nanograms of high molecular weight DNA contained 3000 copies of the albumin gene. The primer set for HTLV-1 tax gene was PXF 5'-GAAACCGTCAAGCACAGCTT-3' positioned at 7163 ± 7182 and PXR 5'-TCTCCAAACACGTAGACTGGGT-3' positioned at 7385 ± 7364. The primer set for albumin was 5'-GCTGTCATCTCTTGTGGGCTGT-3' positioned at 16283 ± 16304 and 5'-ACTCATGGGAGCTGCTGGTTC-3' positioned at 16442 ± 16421 (nucleotide coordinates are numbered according to the albumin Genbank reference: HUMALBGC) (Minghetti et al., 1986) . The TaqMan probe consisted of an oligonucleotide with 5'-reporter dye and 3'-quencher dye. The¯uorescent reporter dye, Fam (6-carboxyuorescein), was covalently linked to the 5' end of the oligonucleotide. The reporter was quenched by Tamra (6-carboxy-tetramethylrhodamine) at the 3' end. The probe for HTLV-1 tax gene was PXT (5'-TTCCCAGGGTTTGGA-CAGAGTCTTCT-3') positioned at 7331 ± 7355 and for albumin ALB (5'-CCTGTCATGCCCACACAAATCTCT-CC-3') positioned at 16340 ± 16366. TaqMan ampli®cation was carried out in reaction volumes of 50 ml, using the TaqMan PCR core Reagent Kit. Each reaction contained 16 TaqMan buer; 300 nmol/l of each primer; 200 nmol/l of each corresponding¯uorescent probe; 3.5 mmol/l MgCl 2 ; 200 mmol/l dATP, dCTP, dGTP; 400 mmol/l dUTP; 1.25 U of AmpliTaq TM Gold, and 0.5 U AmpErase TM uracil Nglycosylase. Each sample was analysed in triplicate, using 500 ng of DNA for tax and 50 ng for albumin in each reaction. Thermal cycling was initiated with 2 min incubation at 508C, followed by a ®rst denaturation step of 10 min at 958C, then 45 cycles of 15 s. At 958C and of 1 min at 588C (for tax) or at 698C (for albumin).
Molecular detection of HTLV-1 integration and semiquantitative analysis of HTLV-1 circulating clones by ligation mediated PCR (LMPCR) LMPCR and run-o were performed as already described (Cavrois et al., 1995; 1996a ,b, 1998 Leclercq et al., 1998 Leclercq et al., , 1999 . Brie¯y, DNA was digested with NlaIII in 16NlaIII buer for 3 h at 378C. Digested DNA was ligated with 10 pmol of BIO1 primer using 20 U of T4 DNA ligase. This was followed by phenol/chloroform extraction and precipitation. Ligated DNA was submitted to 100 cycles of linear extension using the HTLV-1 speci®c BIO2 primer alone. Ten microlitres of this linear PCR reaction were used in a classical PCR ampli®cation using the BIO3 and BIO4 primer pair. Sequences of oligonucleotides have been previously published . Ampli®cation conditions were as before with 50 pmol of each primer, again in a ®nal volume of 100 ml.
There is a stochastic element to the ampli®cation of low frequency HTLV-1 integration sites (Cavrois et al., 1995) . Quadruplicate LMPCR analysis of NlaIII digested p4.39 DNA, bearing an integrated HTLV-1 provirus, showed that above 500 copies (diluted in 1 mg, *150 000 cell equivalents), detection was 4/4. However at 100, 50 and 510 copies, detection was 2/4, 1/4, and 0/4 respectively. Accordingly, DNA samples from Ss+ and Ss7 HTLV-1 carriers were analysed in quadruplicate (4 *0.5 mg).
